MATX vs TECH · P/E 7.5, rev $3.42B vs P/E 65, rev $1.22B
Matson Inc (MATX) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Matson Inc (MATX) is a marine shipping company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported MATX revenue for 2024-12-31 was $3.42B. Net income was $476.4M. Revenue was up 10.6% from 2023-12-31 to 2024-12-31. MATX currently screens at market cap $3.69B and trailing P/E 7.5.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
MATX currently screens at market cap $3.69B and trailing P/E 7.5. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the MATX and TECH stock pages for the full models.
Not investment advice.